In vitro inhibitory effect of antituberculosis drugs on clinical and environmental strains of Coccidioides posadasii

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 3, 2006, Pages 575-579

  de Aguiar Cordeiro, Rossana ^a,b   Brilhante, Raimunda Sâmia Nogueira ^a   Rocha, Marcos Fábio Gadelha ^a,b   Fechine, Maria Auxiliadora Bezerra ^a   de Camargo, Zoilo Pires ^c   Sidrim, José Júlio Costa ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; Coccidioidomycosis; Pulmonary tuberculosis; Susceptibility testing

Indexed keywords

ANTIINFECTIVE AGENT; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; COCCIDIOIDES; CONTROLLED STUDY; DILUTION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS GROWTH; HUMAN; IN VITRO STUDY; LUNG TUBERCULOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTIFUNGAL AGENTS; ANTITUBERCULAR AGENTS; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS; TIME FACTORS;

EID: 33747874638     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl290     Document Type: Article

References (20)

1. Castañeda-Godoy R, Laniado-Laborín R. Coexistencia de tuberculosis y coccidioidomicosis. Presentación de dos casos clínicos. Rev Inst Nal Enf Resp Mex 2002; 15: 98-101.
2. Cox RA, Magee DM. Coccidioidomycosis: host response and vaccine development. Clin Microbiol Rev 2004; 17: 804-39.
3. Castelo Filho A, Kritski AL, Barreto AW et al. II Consenso Brasileiro de Tuberculose: Diretrizes Brasileiras para Tuberculose 2004. J Bras Pneumol 2004; 30: S57-86.
4. Fisher MC, Koenig GL, White TJ et al. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 2002; 94: 73-84.
5. Sidrim JJC, Silva LCI, Nunes JMA et al. Le nord-est brésilien, région dendémie de coccidioidomycose? A propos dune microépidémie. J Mycol Med 1997; 7: 37-9.
6. Wanke B, Lazera M, Monteiro PC et al. Investigation of an outbreak of endemic coccidioidomycosis in Brazil's northeastern state of Piaui with a review of the occurrence and distribution of Coccidioides immitis in three other Brazilian states. Mycopathologia 1999; 148: 57-67.
7. Paixão GC, Rocha MFG, Sidrim JJC. Coccidioidomicose e blastomicose. In: Sidrim JJC, Rocha MFG, eds. Mycologia Médica à Luz de Autores Contemporâneos. Rio de Janeiro: Editora Guanabara Koogan, 2004; 237-51.
8. Diógenes MJN, Jamacuru WF, Silva MAB et al. Inquérito epidemiológico com esferulina em Jaguaribara, CE, Brasil, 1993. An Bras Derm 1995; 70: 525-9.
9. Ferreira AAA, Queiroz KCS, Torres KP et al. Os fatores associados à tuberculose pulmonar e a baciloscopia: Uma contribuição ao diagnóstico nos serviços de saúde pública. Rev Bras Epidemiol 2005; 8: 142-9.
10. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-Forming Filamentous Fungi: Approved Standard M38-A. NCCLS, Wayne, USA, 2002.
11. Hector RF, Laniado-Laborin R. Coccidioidomycosis - a fungal disease of the Americas. PLoS Med 2005; 2: E2.
12. Galgiani JN. Coccidioidomycosis: A regional disease of national importance. Rethinking approaches for control. Ann Intern Med 1999; 130: 293-300.
13. Cohen R, Bos J, Webb PA. Coexisting coccidioidomycosis and tuberculosis in children; report of three cases. Arch Pediatr 1952; 69: 267-72.
14. Cotton BH, Penido JR, Birsner JW et al. Coexisting pulmonary coccidioidomycosis and tuberculosis; a review of twenty-four cases. Am Rev Tuberc 1954; 70: 109-20.
15. Petri WA. Drugs used in the chemotherapy of tuberculosis, Mycobacterium avium complex disease, and leprosy. In: Hardman JG, Limbard LE, eds. The Pharmacological Basis of Therapeutics. 10th edn. New York: McGraw-Hill, 2001; 1273-94.
16. Zhang Y, Wade MM, Scorpio A et al. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 2003; 52: 790-5.
17. Hector RF, Zimmer BL, Pappagianis D. Microtiter method for MIC testing with spherule-endospore-phase Coccidioides immitis. J Clin Microbiol 1988; 26: 2667-8.
18. Cordeiro RA, Brilhante RS, Rocha MF et al. In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil. Mycopathologia 2006; 161: 21-6.
19. Rifkind D, Crowder ED, Hyland RN. In vitro inhibition of Coccidioides immitis strains with amphotericin B plus rifampin. Antimicrob Agents Chemother 1974; 6: 783-4.
20. Huppert M, Pappagianis D, Sun SH et al. Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo. Antimicrob Agents Chemother 1976; 9: 406-13.